Free Trial

IM Cannabis Q2 2024 Earnings Report

IM Cannabis logo
$2.08 +0.08 (+4.00%)
(As of 12/20/2024 05:31 PM ET)

IM Cannabis EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.84
Beat/Miss
Beat by +$0.67
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$10.78 million
Expected Revenue
$9.62 million
Beat/Miss
Beat by +$1.16 million
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

IM Cannabis Earnings Headlines

IM Cannabis Corp Raises Funds Amid Global Challenges
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
Rare "crisis signal" triggers for third time in U.S. market
A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years.
IM Cannabis Reports Third Quarter Financial Results
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings